Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial

DOI:10.1016/s0140-6736(25)01811-2
作者：Shun Lu, Jie Wang, Nong Yang, Dongqing Lv, Lijuan Chen, Lin Wu, Xingya Li, Longhua Sun, Yongfeng Yu, Bo Jin, Lin Yang, Yubiao Guo, Haipeng Xu, Tienan Yi, Aiping Zeng, Xiaorong Dong, Jianhua Chen, Zipi
文献类型：期刊论文
补充材料：只需要正文